Skip to main content
Clinical Trials/NCT06110442
NCT06110442
Completed
Not Applicable

Opportunistic Fragility Fracture Risk Estimates From Radiographs

University of Exeter1 site in 1 country497 target enrollmentJuly 1, 2023
ConditionsOsteoporosis

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Osteoporosis
Sponsor
University of Exeter
Enrollment
497
Locations
1
Primary Endpoint
T-scores as calculated by IbexBH and DXA
Status
Completed
Last Updated
last year

Overview

Brief Summary

The proposed study will predict a patients' risk of having osteoporosis by using a combination of the IBEX BH (Bone Health) software outputs and other clinical risk factors such as age, gender, medical history and lifestyle. A comparison will be made between the IBEX BH prediction and the one calculated in current clinical practice using a tool called FRAX (Fracture Risk Assessment Tool) which combines clinical risk factors with results from a Dual Energy X-ray Absorptiometry (DXA) assessment.

The study involves conducting these assessments on several new anatomies including Knee, Ankle and Pelvis, to extend the market reach and clinical utility of IBEX BH. The expected outcome of the study is that the IBEX BH will offer better decision support to clinicians in terms of referral on for a DXA scan or osteoporosis investigations than available today.

Registry
clinicaltrials.gov
Start Date
July 1, 2023
End Date
December 31, 2024
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Male or female
  • 50 years of age or over

Exclusion Criteria

  • Women who are pregnant or are breastfeeding.
  • Participants who have sustained fractures in both hips.
  • Unwilling or unable to provide informed consent.
  • For the collection of healthy-normal data in the study.
  • Inclusion Criteria:
  • Male or female
  • 20-30 years of age
  • Exclusion Criteria:
  • Women who are pregnant or are breastfeeding.
  • Participants who have sustained fractures in both hips.

Outcomes

Primary Outcomes

T-scores as calculated by IbexBH and DXA

Time Frame: 2 hours on 1 visit only

Secondary Outcomes

  • Estimated 10-year risk of major osteoporotic fracture as outputted by FRAX (with and without DXA aBMD (Areal Bone Mineral Density) and IbexBH)(2 hours on same visit as above)

Study Sites (1)

Loading locations...

Similar Trials